Inspiring Collaboration

Xavier University leads the pharmaceutical industry through some of the most pressing challenges we face in our industry, such as Global Outsourcing and Supplier Integrity. Xavier has created the most comprehensive, innovative and impactful alliances, world renowned experts within and outside the pharmaceutical industry, prominent former FDA experts, and with organizations who represent the total cross-function of our industry. These alliances bring together industry leaders and regulators in dynamic forums that inspire the kind of collaboration that leads to sustainable innovation, improvement and increased patient safety.

Among the FDA leaders who have addressed our conferences are Deborah Autor, FDA Deputy Commissioner for Global Regulatory Operations and Policy; Michael Levy, Director of the FDA Office of Drug Security, Integrity and Recalls; Brian Hasselbalch, Office of Manufacturing and Product Quality; and Kathleen Culver, Field Investigator and Drug Pre-Approval Manager.

Industry leaders who have spoken at our conferences include Steve Niedelman, King & Spalding (former Deputy Associate Commissioner); Janeen Skutnik-Wilkinson, Director, Pfizer; Sharon Johnson, Sr. Vice President, Catalent; John Curran, Distinguished Scientist, Merck; Alan Minsk, Partner, Arnall Golden Gregory, LLP; and James O’Reilly, JD, Professor of Law, University of Cincinnati.

Collectively, our conferences, resources, and impactful training programs address the industry's most pressing issues with sustainable solutions for you – and your organization.